Z-0630-2016 Class I Terminated
FDA device recall Z-0630-2016 was initiated by Arkray Factory USA, Inc. on Dec 18, 2015 and is designated Class I. Reason for recall: One lot each of SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip are being recalled due to a lowered reaction rate in the reagent pad for glucose. The affected… The recall status is terminated (terminated Jan 4, 2017). Affected quantity: 88 boxes (25 foil packaged test strips per box).
Recall details
- Product Type
- Devices
- Report Date
- Jan 27, 2016
- Initiation Date
- Dec 18, 2015
- Termination Date
- Jan 4, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 88 boxes (25 foil packaged test strips per box)
Product description
arkray SPOTCHEM II Glucose Reagent test strips, Item No. 77101, MEDTEST DX Catalog # 77424. For the in vitro quantitative determination of glucose in human plasma from whole blood samples.
Reason for recall
One lot each of SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip are being recalled due to a lowered reaction rate in the reagent pad for glucose. The affected lots will display a result of approximately 300 to 400 mg/dL for any glucose value that exceeds the upper limit of 416 mg/dL.
Distribution pattern
Distributed in the states of FL, IL, KY, MI, NC, NY, OH, and TN.
Code information
Lot Number EA4M78
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0630-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026